PRECISION BIOSCIENCES INC — Director's Dealing 2019

Apr 1, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2019-04-01

Reporting Person: venBio Global Strategic Fund, L.P. (Director, 10% Owner)
Reporting Person: venBio Global Strategic GP, L.P. (10% Owner)
Reporting Person: venBio Global Strategic GP, Ltd. (10% Owner)
Reporting Person: Adelman Robert J (Director, 10% Owner)
Reporting Person: GOODMAN COREY S (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-04-01	Common Stock	P	50000	$16.00	Acquired	50000	Indirect
2019-04-01	Common Stock	C	3747623	—	Acquired	3797623	Indirect
2019-04-01	Common Stock	C	467518	—	Acquired	4265141	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-01	Series A Preferred Stock	$	C	8000000	Disposed		Common Stock (3747623)	Indirect
2019-04-01	Series B Preferred Stock	$	C	998004	Disposed		Common Stock (467518)	Indirect

Footnotes

F1: Each share of the Issuer's preferred stock converted into shares of the Issuer's common stock, $0.000005 par value per share, on a one-for-2.134686 basis upon the closing of the Issuer's initial public offering, after giving effect to the reverse stock split effected by the Issuer in connection with the initial public offering.

F2: venBio Global Strategic GP, LP is the sole general partner of venBio Global Strategic Fund, LP and venBio Global Strategic GP, Ltd. is the sole general partner of venBio Global Strategic GP, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP, Ltd. Each of venBio Global Strategic GP, L.P., venBio Global Strategic GP, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.